<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Psychiatry">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Psychiatry</JournalTitle>
      <Issn>1735-4587</Issn>
      <Volume>6</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2011</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">C677T Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism in Schizophrenia and Bipolar Disorder: An Association Study in Iranian Population</title>
    <FirstPage>1</FirstPage>
    <LastPage>6</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Seyed Masoud</FirstName>
        <LastName>Arzaghi</LastName>
        <affiliation locale="en_US">Psychosomatic Research Group, Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Arash</FirstName>
        <LastName>Hossein-Nezhad</LastName>
        <affiliation locale="en_US">Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Vahid</FirstName>
        <LastName>Shariat</LastName>
        <affiliation locale="en_US">Mental Health Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Ghodsipour</LastName>
        <affiliation locale="en_US">Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Jamal</FirstName>
        <LastName>Shams</LastName>
        <affiliation locale="en_US">Neuroscience Research Center, National Neuroscience Research Network, Shaheed Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Bagher</FirstName>
        <LastName>Larijani</LastName>
        <affiliation locale="en_US">Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Objective: The methylenetetrahydrofolate reductase (MTHFR) gene polymorphism C677T is suspected to be a risk factor for psychiatric disorders, but it remains inconclusive whether the MTHFR polymorphism C677T is imputed to vulnerability to schizophrenia and bipolar disorder.
Method: We prompted impetus to appraise this polymorphism in an Iranian population. Therefore, 90 patients with bipolar disorder type I (BID), 66 patients with schizophrenia diagnosed according to DSM-IV criteria, and 94 unrelated controls with no history of psychiatric disorders were recruited for this study. Genotype distribution and allelic frequencies of C677T polymorphism were investigated.
Results: We found no robust differences between patients with BID and schizophrenia with control participants either for allele frequencies or genotype distribution of MTHFR C677T polymorphism. However, a trend toward an increased risk for T allele was observed in the BID patients [with odds ratio (OR) of 1.28(CI 95%: 0.8-1.31), p&gt;0.05].
Conclusion: However, the present and some previous studies failed to elucidate possible interaction between MTHFR C677T polymorphism and vulnerability to schizophrenia and bipolar disorder; still some associations have been revealed in performed meta-analyses that warrant further studies.</abstract>
    <web_url>https://ijps.tums.ac.ir/index.php/ijps/article/view/340</web_url>
    <pdf_url>https://ijps.tums.ac.ir/index.php/ijps/article/download/340/336</pdf_url>
  </Article>
</Articles>
